Peginterferon alfa-2a

Generic name: Peginterferon Alfa-2a
Dosage form: subcutaneous solution (180 mcg/0.5 mL; 180 mcg/mL)
Drug class: Antiviral interferons

Usage of Peginterferon alfa-2a

Peginterferon Alfa-2a is used alone or with other medicines to treat chronic hepatitis C in adults and children at least 5 years old.

Peginterferon alfa-2a is also used to treat chronic hepatitis B when the virus begins to damage the liver in adults and children at least 3 years old.

Peginterferon alfa-2a may also be used for purposes not listed in this medication guide.

Peginterferon alfa-2a side effects

Get emergency medical help if you have signs of an allergic reaction (hives, difficult breathing, swelling in your face or throat) or a severe skin reaction (fever, sore throat, burning eyes, skin pain, red or purple skin rash with blistering and peeling).

Peginterferon alfa-2a can cause life-threatening infections, autoimmune disorders, serious mood or behavior problems, or a stroke.

Call your doctor at once if you have unusual changes in mood or behavior, such as: depression, irritability, aggression, hallucinations, thoughts about hurting yourself, or falling back into a previous pattern of drug addiction.

Peginterferon alfa-2a may cause serious or fatal side effects. Call your doctor at once if you have:

severe stomach pain with bloody diarrhea;

new or worsening cough, cough with yellow or pink mucus, trouble breathing;

numbness, tingling, or burning in your arms or legs;

pain or burning when you urinate;

sudden numbness or weakness, slurred speech, problems with balance;

vision changes;

low blood cell counts--fever, chills, tiredness, mouth sores, skin sores, easy bruising, unusual bleeding, pale skin, cold hands and feet, feeling light-headed or short of breath;

high or low blood sugar--headache, hunger, confusion, sweating, thirst, increased urination, weakness, fruity breath odor, feeling anxious or shaky, weight loss, or fainting;

pancreatitis--severe pain in your upper stomach spreading to your back, nausea and vomiting;

thyroid problems--weight changes, skin changes, trouble concentrating, feeling hot or cold all the time; or

worsening liver symptoms--swelling around your midsection, nausea, diarrhea, loss of appetite, confusion, drowsiness, yellowing of the skin or eyes, loss of consciousness.

Your next injection may be delayed if you have certain side effects.

Peginterferon alfa-2a can affect growth in children. Tell your doctor if your child is not growing at a normal rate while using peginterferon alfa-2a.

Common side effects of peginterferon alfa-2a may include:

fever, chills;

muscle or joint pain;

headache; or

feeling weak or tired.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Before taking Peginterferon alfa-2a

You should not use peginterferon alfa-2a if:

you are allergic to any type of interferon alfa; or

you have autoimmune hepatitis, or severe liver damage.

When taking peginterferon alfa-2a with other medicine: To make sure all medicines are safe for you, tell your doctor about all your medical conditions, and if you are pregnant or breastfeeding.

Tell your doctor if you have ever had:

both hepatitis B and hepatitis C, or HIV/AIDS;

liver problems other than hepatitis B or C;

heart disease, high blood pressure, or a heart attack;

lung disease;

diabetes, or a thyroid disorder;

colitis (an intestinal disorder);

cancer;

an autoimmune disorder such as rheumatoid arthritis, lupus, or psoriasis;

low blood cell counts;

a hemoglobin blood cell disorder such as sickle-cell anemia or thalassemia;

an organ transplant;

kidney disease;

high triglycerides (a type of fat in the blood);

a drug or alcohol addiction; or

depression, mental illness, suicidal thoughts or actions.

Peginterferon alfa-2a may contain an ingredient that can cause serious side effects or death in very young or premature babies. Do not give peginterferon alfa-2a to a child younger than 1 year old.

You may need to have a negative pregnancy test before starting this treatment.

Peginterferon alfa-2a is sometimes used in combination with ribavirin. Both men and women using ribavirin should use effective birth control to prevent pregnancy. Ribavirin can cause birth defects, miscarriage, or death to an unborn baby if the mother or father is using this medicine.

You should not take ribavirin if you are pregnant, or if you are a man and your sex partner is pregnant. Use effective birth control to prevent pregnancy. Keep using birth control for at least 6 months after your last dose of ribavirin.

Tell your doctor right away if a pregnancy occurs while either the mother or the father is using ribavirin.

You should not breastfeed while using peginterferon alfa-2a. Women with HIV or AIDS should not breastfeed a baby. Even if your baby is born without HIV, the virus may be passed to the baby in your breast milk.

Relate drugs

How to use Peginterferon alfa-2a

Follow all directions on your prescription label and read all medication guides or instruction sheets. Use the medicine exactly as directed.

Peginterferon alfa-2a is injected under the skin, usually once per week on the same day each week. A healthcare provider may teach you how to properly use the medication by yourself.

Read and carefully follow any Instructions for Use provided with your medicine. Ask your doctor or pharmacist if you don't understand all instructions.

Prepare an injection only when you are ready to give it. Do not use if the medicine looks cloudy, has changed colors, or has particles in it. Call your pharmacist for new medicine.

Peginterferon alfa-2a doses are based on body surface area (height and weight) in children. Your child's dose needs may change if the child is still growing.

Your dose needs may change if you switch to a different brand, strength, or form of this medicine. Avoid medication errors by using only the form and strength your doctor prescribes.

You will need frequent medical tests. Your vision and lung function may also need to be checked.

Each vial (bottle), prefilled syringe, or auto-injector device is for one use only. Throw it away after one use, even if there is still medicine left inside.

Store in the refrigerator, protected from light. Do not shake or freeze this medicine.

Follow the package directions about letting your medicine reach room temperature before injecting your dose. Do not leave the medicine out of a refrigerator for longer than 24 hours.

Use a needle and syringe only once and then place them in a puncture-proof "sharps" container. Follow state or local laws about how to dispose of this container. Keep it out of the reach of children and pets.

Warnings

You should not use peginterferon alfa-2a with ribavirin if you are pregnant, or if you are a man whose sex partner is pregnant. Use effective birth control to prevent pregnancy while taking ribavirin and for at least 6 months after your last dose.

Peginterferon alfa-2a may cause serious or fatal side effects.

Tell your doctor about any new or worsening mood symptoms, such as feeling irritable, hostile, aggressive, depressed, or having thoughts about suicide or hurting yourself.

Call your doctor right away if you have symptoms such as chest pain, fast heartbeats, trouble breathing, numbness or weakness, vision or speech problems, fever, chills, a cough with mucus, burning when you urinate, or bloody diarrhea.

What other drugs will affect Peginterferon alfa-2a

Tell your doctor about all your other medicines, especially:

methadone;

telbivudine;

theophylline; or

any medicine to treat HIV or AIDS.

This list is not complete. Other drugs may affect peginterferon alfa-2a, including prescription and over-the-counter medicines, vitamins, and herbal products. Not all possible drug interactions are listed here.

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.